The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts).
 
Shirish M. Gadgeel
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - ACEA Biosciences (Inst); Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst)
 
Jaclyn Ventimiglia
No Relationships to Disclose
 
Gregory Peter Kalemkerian
Consulting or Advisory Role - BioMed Valley Discoveries (I); Takeda (I); Unum Therapeutics (I)
Research Funding - Astex Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Merck (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst)
 
Mary J. Fidler
Consulting or Advisory Role - Abbvie; Abbvie (I); AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech
Speakers' Bureau - Celgene; Genentech; Merck
 
Wei Chen
No Relationships to Disclose
 
Ammar Sukari
Consulting or Advisory Role - Eisai
Speakers' Bureau - Merck; Novartis
 
Balazs Halmos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Foundation Medicine; Genentech/Roche; Lilly; Pfizer
Research Funding - ARIAD; AstraZeneca; Boehringer Ingelheim; Merck; Mirati Therapeutics; Roche/Genentech
 
Julie Boerner
No Relationships to Disclose
 
Antoinette J. Wozniak
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Genentech/Roche; Lilly; Novartis
Research Funding - Astex Pharmaceuticals; Boehringer Ingelheim
 
Cathy Galasso
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck; Newlink Genetics (Inst); Pfizer (Inst)